Type 1 diabetes

Metabolic dysfunction‐associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes

Diabetes Obes MetabPublished Cross-sectional study

Authors' conclusion

TIR, TAR, TBR, waist circumference and systolic blood pressure were independently associated with MASLD.

Study context

Population
Adults with T1D using a continuous glucose monitoring (CGM) device; median age 49 [34–61] years, male sex 58%, median diabetes duration 29 [17–38] yearsconsecutive
Participants
302 adults
Exposure
MASLD vs no MASLD
Outcome
Relationship between CGM-derived glucometrics and MASLD
Methodological detailsconsecutive participants, backward multivariable logistic regression
  • Consecutive participants
  • Backward multivariable logistic regression

Main finding

As reported in the abstract

TIR independently associated with MASLD
P = .028
Time above range (TAR) independently associated with MASLD
P = .007
Time below range (TBR) independently associated with MASLD
P = .036
Waist circumference independently associated with MASLD
P < .001
Systolic blood pressure independently associated with MASLD
P = .029

Observational data: associations, not effects.

Further findings

MetS prevalence

P < 0.0001

Glucometrics, univariable comparison · TIR lower with MASLD
P = 0.038
Glucometrics, univariable comparison · TBR lower with MASLD
P = 0.032
Glucometrics, univariable comparison · TAR higher with MASLD
P = 0.006
Glucometrics, univariable comparison · HbA1c did not reach significance
P = 0.068
Glucometrics, univariable comparison — Mean TIR, whole cohort
55% ± 16%

MASLD prevalence

MASLD present
17%
Metabolic syndrome (MetS)
32%

Glucometrics, univariable comparison

No differences for the glycaemia risk index

Original publication

Metabolic dysfunction‐associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes. Diabetes Obes Metab. Published 25 June 2024. doi:10.1111/dom.15723

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.